KTTAW

Pasithea Therapeutics warrants are derivative securities that provide holders the right to purchase shares of common stock at a predetermined exercise price. These warrants offer leveraged exposure to the biotechnology company's development progress and clinical trial outcomes. Warrant holders can benefit from stock price appreciation while limiting initial capital investment.